feed,title,long_url,short_url
🔐MarketWatch,Crispr Therapeutics’ stock soars as FDA-panel meeting raises hopes sickle-cell-disease drug will be approved,http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-728E-1B98B445DB06%7D&siteid=rss&rss=1,https://da.gd/Aks3Qc
